Susquehanna International Group’s Apexigen, Inc. Common Stock APGN Stock Holding History

Susquehanna International Group’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,546	Closed	-$7.77K	–	13575
2023 Q1	$7.77K	Buy	15,546 +3,695	+31%	+$4.45K	﹤0.01%	12241
2022 Q4	$8.18K	Buy	+11,851	New	+$23.1K	﹤0.01%	11970
2022 Q3	–	Sell	-113,358	Closed	-$922K	–	14472
2022 Q2	$1.15M	Buy	113,358 +95,404	+531%	+$966K	﹤0.01%	6176
2022 Q1	$181K	Buy	+17,954	New	+$180K	﹤0.01%	11362
2021 Q4	–	Sell	-11,587	Closed	-$115K	–	14195
2021 Q3	$115K	Buy	+11,587	New	+$115K	﹤0.01%	11975

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group's APGN Position: Q2 2023 in Review

Susquehanna International Group sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2023, closing a stake of 15,546 shares — an estimated $7.77K sold.

Susquehanna International Group first reported a position in APGN in Q3 2021 and held it in 5 quarters. The position peaked at $1.15M in Q2 2022. 17 funds tracked by Wall St. Rank hold APGN as of Q2 2023.

Susquehanna International Group reported no remaining Apexigen, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 15,546 Apexigen, Inc. Common Stock shares in Q2 2023, an estimated $7.77K.
Susquehanna International Group first reported a position in Apexigen, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Susquehanna International Group's Apexigen, Inc. Common Stock position peaked at $1.15M in Q2 2022.
17 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.